![]() |
![]() |
![]() |
|||||||
![]() ![]() ![]() ![]() |
|||||||||
![]() |
| ||||||||
![]() |
![]() |
![]() |
|||||||
ISMP Canada NewsDecember 2, 2019: Health Canada: Important Safety Update on XELJANZ / XELJANZ XR (tofacitinib) – Risk of Thrombosis |
![]() |
||||||||
![]() |
![]() |
Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved. |